QA: FIVE PRIME THERAPEUTICS INC. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001175505_2021_FIVE_PRIME_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001175505')"}

Graph

Absolute values for 0001175505, FIVE PRIME THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 292,408,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 11,209,000
3 remainder_Assets 28,033,000
4 LiabilitiesCurrent 22,184,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 40,557,000
9 ResearchAndDevelopmentExpense 65,491,000
10 remainder_Expenses -6,630,000
11 remainder_Revenues 13,178,000
12 remainder_NetIncome 1,912,000
13 remainder_ComprehensiveNetIncome -103,000
  yvar yval
0 Assets 331,650,000
1 Liabilities 22,184,000
2 Expenses 99,418,000
3 Revenues 13,178,000
4 StockholdersEquity 309,466,000
5 NetIncome -84,328,000
6 ComprehensiveNetIncome -84,379,500
7 BaseVar 234,222,500
8 EconomicCapitalRatio 2.53

Edgar->Model Mapping

Feature Distribution

Change over Time